acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 13 Jan 2021 Positiva preliminära data från Acarixs undersökande hjärtsviktstudie SEISMO &nb... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 09 Dec 2020 Acarix announces the last patient included in Dan-NICAD II study Press release Malmö, Sweden December 9, 2020 Acarix announces the last patient included in Dan-NICAD II study After the inclusi... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 09 Dec 2020 Acarix AB meddelar att den sista patienten i Dan-NICAD II studien har inkluderats Pressmeddelande Malmö, 9 december 2020 Acarix AB meddelar att den sista patienten i Dan-NICAD II studien har inkluderats Efter... Continue reading
acarix Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 26 Nov 2020 FDA identifierar unik kod för CADScor® Pressmeddelande (MAR) Malmö, 26 november 2020 FDA identifierar unik kod för CADScor® Efter gårdagens meddelande o... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 26 Nov 2020 FDA identifies exclusive code for the CADScor® Press release (MAR)Malmö, Sweden, November 26, 2020 FDA identifies exclusive code for the CADScor® After yesterday’s a... Continue reading
acarix Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 25 Nov 2020 Acarix erhåller marknadsgodkännande för CADScor® System för försäljning på den amerikanska marknaden Pressmeddelande (MAR) Malmö, Sverige, 25 november 2020 Acarix erhåller marknadsgodkännande för CADScor® ... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 25 Nov 2020 Acarix receives US market approval for the CADScor® System Press release (MAR)Malmö, Sweden November 25, 2020 Acarix receives US market approval for the CADScor® System Acarix AB (pu... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 18 Nov 2020 Positiva resultat från Acarix-jämförelseanalys presenterades på den ledande hälsoekonomiska konferensen ISPOR Pressmeddelande Malmö, Sverige, 18 november 2020 Positiva resultat från Acarix-jämförelseanalys presenterades p&... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 18 Nov 2020 Positive results from Acarix study presented at ISPOR, a leading health economics conference Press releaseMalmö, Sweden November 18, 2020 Positive results from Acarix study presented at ISPOR, a leading health economics co... Continue reading
acarix English, Interim, IR, MAR, News, Q3, Regulatory, Report November 18, 2024 12 Nov 2020 Correction: Interim report 2020-01-01 to 2020-09-30 Press release (MAR) Malmö, November 12, 2020 Correction: Interim report 2020-01-01 to 2020-09-30 In the interim report that Ac... Continue reading
acarix Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish November 18, 2024 12 Nov 2020 Rättelse: Delårsrapport 2020-01-01 till 2020-09-30 Press release (MAR) Malmö, 12 november, 2020 Rättelse: Delårsrapport 2020-01-01 till 2020-09-30 I den delår... Continue reading
acarix English, Interim, IR, MAR, News, Q3, Regulatory, Report November 18, 2024 12 Nov 2020 A Successful Rights Issue with Focus on Sales! Press release (MAR) Malmö, November 12, 2020 Acarix AB (publ) publishes Interim Report, January – September 2020 A Success... Continue reading